Aqueous emulsion polymerization process for producing fluoropolymers

Information

  • Patent Grant
  • 8404790
  • Patent Number
    8,404,790
  • Date Filed
    Thursday, February 23, 2012
    12 years ago
  • Date Issued
    Tuesday, March 26, 2013
    11 years ago
Abstract
A method of making a fluoropolymer in the presence of a fluorinated surfactant.
Description
BACKGROUND

Commonly known or commercially employed fluoropolymers include polytetrafluoroethylene (PTFE), copolymers of tetrafluoroethylene (TFE) and hexafluoropropylene (HFP) (FEP polymers), copolymers of TFE and perfluoroalkoxy copolymers (PFA polymers), copolymers of TFE and ethylene (ETFE polymers), terpolymers of TFE, HFP, and vinylidene fluoride (VDF) (THV polymers) and polymers of VDF (PVDF polymers). Commercially employed fluoropolymers also include fluoroelastomers and thermoplastic fluoropolymers. Fluoropolymers and their applications are further described, for instance, in “Modern Fluoropolymers”, edited by John Scheirs, John Wiley & Sons Ltd., 1997. The making of such fluoropolymers generally involves the polymerization of gaseous monomers, i.e. monomers that under ambient conditions of temperature and pressure exist as a gas. Several polymerization methods are known to produce fluoropolymers. Such methods include suspension polymerization as described in e.g. U.S. Pat. Nos. 3,855,191, 4,439,385 and EP 649,863; aqueous emulsion polymerization as described in e.g. U.S. Pat. Nos. 3,635,926 and 4,262,101; solution polymerization as described in U.S. Pat. Nos. 3,642,742, 4,588,796 and 5,663,255; polymerization using supercritical CO2 as described in JP 46011031 and EP 964,009 and polymerization in the gas phase as disclosed in U.S. Pat. No. 4,861,845.


Currently, the most commonly employed polymerization methods include suspension polymerization and aqueous emulsion polymerization. Aqueous emulsion polymerization often involves polymerization in the presence of a fluorinated surfactant, which is generally used to ensure the stabilization of the polymer particles formed. Accordingly, the emulsion polymerization process differs from suspension polymerization in which generally no surfactant is used and which generally results in substantially larger polymer particles than are formed in aqueous emulsion polymerization.


In aqueous emulsion polymerization, the polymerization speed, yield of polymer, comonomer incorporation, particle size and particle number are dependent on each other as well as on the level of emulsifier content. In order to optimize polymer yield, polymerization time and particle size, one can modify the pressure of gaseous monomer(s), the temperature, and the type and amount of fluorinated surfactant. For example, EP 612,770 describes the use of high amounts of fluorinated surfactant to increase the polymerization speed. Increasing the amount of fluorinated surfactant, however, has the disadvantage of increasing the cost of polymerization and may also be environmentally undesirable.


U.S. Pat. No. 4,864,006 describes an aqueous emulsion polymerization process wherein an aqueous micro-emulsion of a perfluoropolyether is added to a polymerization reaction. The micro-emulsion is characterized as a mono-phase solution that is stable in the long run without providing “dispersion energy”. It thus seems that the micro-emulsion discussed forms upon simple mixing of the components without the need to apply “dispersion energy” through the use of special emulsifying equipment. Accordingly, the type of surfactants that can be used are limited, as not all surfactants are able to form such a micro-emulsion. The limitations on the useful surfactants may further complicate the polymerization process. For example, as shown in the examples of U.S. Pat. No. 4,864,006, the micro-emulsion of the perfluoropolyether is formed using a perfluoropolyether that has a carboxylic acid group as a surfactant. Such surfactants may be expensive. Further, as shown in the examples of U.S. Pat. No. 4,864,006, the micro-emulsion forms at elevated temperatures.


EP 969,027 describes a process for making PTFE dispersions. In this patent application, a micro-emulsion of a perfluoropolyether obtained through emulsification with a perfluoropolyether surfactant is used to prepare the PTFE dispersion. Although small polymer particles are achieved in this process, it appears that large amounts of surfactant are used. The use of large amounts of surfactants is disadvantageous in that it makes the process more costly and may put environmental burdens on the process.


U.S. Pat. No. 5,895,799 describes a micro-emulsion polymerization of TFE to produce very small particle dispersions of PTFE in water. The polymerization of TFE itself proceeds in a micro-emulsion of liquid perfluorinated hydrocarbons. This micro-emulsion is formed by adding the perfluorinated hydrocarbon liquid and a fluorinated surfactant to water at a temperature and in proportions that result in a micro-emulsion. As is well known, micro-emulsions only form when the surfactant is used above its critical micelle concentration (CMC). See P. Lovell, “Emulsion Polymerization and Emulsion Polymers”, J. Wiley, 1997, pages 700-739. As a result, the process taught in U.S. Pat. No. 5,895,799 will generally require large amounts of surfactant, typically much higher than the amounts employed in conventional aqueous emulsion polymerization processes that use surfactants in amounts below the CMC.


SUMMARY

The present invention recognizes that it is now desirable to improve the aqueous emulsion polymerization of fluorinated monomers to produce fluoropolymers. It is in particular desirable to reduce the polymerization time, improve the yield of polymer solids obtained and/or to obtain fluoropolymer dispersions having a small particle size. It is further desirable to simultaneously use a surfactant that has a low toxicity and/or shows little or no bioaccumulation. Further, the surfactant should have good chemical and thermal stability enabling polymerization over a wide range of conditions of temperature and pressure.


In one aspect of the present invention, there is provided a method of making a fluoropolymer comprising polymerizing one or more fluorinated monomers in an aqueous emulsion polymerization in the presence of a fluorinated surfactant selected from fluorinated surfactants of formula (I):

[RfO-L-CO2]iXi+  (I)

wherein Rf is selected from a partially fluorinated alkyl group, a fully fluorinated alkyl group, a partially fluorinated alkyl group that is interrupted with one or more oxygen atoms, and a fully fluorinated alkyl group that is interrupted with one or more oxygen atoms; L is selected from a partially fluorinated alkylene group, a fully fluorinated alkylene group, a partially fluorinated alkylene group that is interrupted with one or more oxygen atoms, and a fully fluorinated alkylene group that is interrupted with one or more oxygen atoms; Xi+ represents a cation having the valence i; and i is 1, 2, or 3; further wherein at least part of the fluorinated surfactant is added to the aqueous phase as an aqueous mixture with at least one fluorinated liquid, and further wherein when the fluorinated surfactant is a perfluorinated polyethercarboxylic acid, the fluorinated liquid is not a perfluoropolyether.


In a further aspect of the present invention, there is provided a method of making a fluoropolymer comprising polymerizing one or more fluorinated monomers in an aqueous emulsion polymerization to give an aqueous dispersion, wherein polymerizing is in the presence of a fluorinated surfactant selected from:


i) fluorinated surfactants of formula (II):

CF3—(OCF2)m—O—CF2—X  (II)

wherein m has a value of from 1 to 6 and X represents a carboxylic acid or salt thereof;


ii) fluorinated surfactants of formula (III):

CF3—O—(CF2)3-(OCF(CF3)CF2)z—O-L-Y  (III)

wherein z has a value of 0, 1, 2, or 3; L represents a divalent linking group selected from —CF(CF3)—, —CF2—, and —CF2CF2—, and Y represents a carboxylic acid group or salt thereof;


iii) fluorinated surfactants of formula (IV):

[Rf1—(O)t—CQH—(CF2)p—O]n—R-G  (IV)

wherein Rf1 represents a partially or fully fluorinated aliphatic group optionally interrupted with one or more oxygen atoms, Q represents F or CF3, R is an aliphatic or aromatic hydrocarbon group, G represents a carboxylic or sulfonic acid or salt thereof, t is 0 or 1, and n is 1, 2, or 3;


iv) fluorinated surfactants of formula (V)

Rf2—(O)s—CHF—(CF2)v—X  (V)

wherein Rf2 represents a partially or fully fluorinated aliphatic group optionally interrupted with one or more oxygen atoms, s is 0 or 1, v is 0 or 1, and X is a carboxylic acid or salt thereof;


v) fluorinated surfactants of formula (VI)

Rf3—O—CF2CF2—X  (VI)

wherein Rf3 represents a linear or branched perfluoroalkyl group having 1, 2, 3, or 4 carbon atoms and X represents a carboxylic acid group or salt thereof; further wherein at least part of the fluorinated surfactant is added to the aqueous phase as an aqueous mixture with at least one fluorinated liquid, the aqueous mixture comprising droplets having an average droplet diameter of not more than 2000 nm.


At least part of the fluorinated surfactant is added to the aqueous phase as an aqueous mixture with at least one fluorinated liquid. The fluorinated liquid may be polymerizable or non-polymerizable.


In a further aspect, the present invention relates to an aqueous mixture comprising a fluorinated surfactant selected from:


i) fluorinated surfactants of formula (II):

CF3—(OCF2)m—O—CF2—X  (II)

wherein m has a value of from 1 to 6 and X represents a carboxylic acid or salt thereof;


ii) fluorinated surfactants of formula (III):

CF3—O—(CF2)3-(OCF(CF3)CF2)z—O-L-Y  (III)

wherein z has a value of 0, 1, 2, or 3; L represents a divalent linking group selected from —CF(CF3)—, —CF2—, and —CF2CF2—, and Y represents a carboxylic acid group or salt thereof;


iii) fluorinated surfactants of formula (IV):

[Rf1—(O)t—CQH—(CF2)p—O]n—R-G  (IV)

wherein Rf1 represents a partially or fully fluorinated aliphatic group optionally interrupted with one or more oxygen atoms, Q represents F or CF3, R is an aliphatic or aromatic hydrocarbon group, G represents a carboxylic or sulfonic acid or salt thereof, t is 0 or 1, and n is 1, 2, or 3;


iv) fluorinated surfactants of formula (V)

Rf2—(O)s—CHF—(CF2)v—X  (V)

wherein Rf2 represents a partially or fully fluorinated aliphatic group optionally interrupted with one or more oxygen atoms, s is 0 or 1, v is 0 or 1, and X is a carboxylic acid or salt thereof;


v) fluorinated surfactants of formula (VI)

Rf3—O—CF2CF2—X  (VI)

wherein Rf3 represents a linear or branched perfluoroalkyl group having 1, 2, 3, or 4 carbon atoms and X represents a carboxylic acid group or salt thereof; the aqueous mixture further comprising at least one fluorinated liquid and, wherein the surfactant and the fluorinated liquid form emulsified droplets, further wherein the droplets have an average droplet diameter of from 20 nm to 2000 nm.


In a further aspect, the present invention relates to an aqueous mixture comprising a fluorinated surfactant selected from fluorinated surfactants of formula (I):

[RfO-L-CO2]iXi+  (I)

wherein Rf is selected from a partially fluorinated alkyl group, a fully fluorinated alkyl group, a partially fluorinated alkyl group that is interrupted with one or more oxygen atoms, and a fully fluorinated alkyl group that is interrupted with one or more oxygen atoms; L is selected from a partially fluorinated alkylene group, a fully fluorinated alkylene group, a partially fluorinated alkylene group that is interrupted with one or more oxygen atoms, and a fully fluorinated alkylene group that is interrupted with one or more oxygen atoms; Xi+ represents a cation having the valence i; and i is 1, 2, or 3; further comprising at least one fluorinated liquid, and further wherein when the fluorinated surfactant is a perfluorinated polyethercarboxylic acid, the fluorinated liquid is not a perfluoropolyether.


By the term “liquid” or “fluid” in connection with the present invention are included compounds that are liquid at a temperature of 20° C. and a pressure of 1 atm as well as compounds that are liquid under the polymerization conditions.


By the term “not miscible with water” is meant a liquid that forms a separate phase absent surfactant when mixed with water in the amounts in which liquid is employed in the polymerization described.


By the term “non-polymerizable” is meant a compound that, even though present in a reaction medium, is not incorporated into a polymer formed in an amount that can be measured. For instance, a compound that has no olefinic groups may be non-polymerizable in the presence of a radical polymerization. Some compounds having olefinic groups may also be non-polymerizable when in the presence of a radical polymerization of tetrafluoroethylene, despite the presence of a double bond. For instance, compounds containing double bonds that are sterically hindered, such as 1,2-(perfluoro-n-butyl)ethylene are known to be non-polymerizable. See, U.S. Pat. No. 5,182,342.


In the present application, when the term is used “interrupted with one or more oxygen atoms”, it is meant that one or more ether groups may be present in the aliphatic group. That is, for instance, where two oxygen atoms are present, they are separated by at least one carbon atom, so as to form a di-ether. Peroxide structures are not contemplated by the term “interrupted by one or more oxygen atoms”.







DETAILED DESCRIPTION

For the sake of convenience, the term “fluorinated carboxylic acid” is hereinafter used to indicate a free acid as well as salts thereof.


The advantages of the process of the present invention are conveniently achieved by adding to the aqueous phase of an emulsion polymerization system at least part of the fluorinated surfactant selected from formula (I) as an aqueous mixture with a fluorinated liquid. It has been found that the fluorinated surfactants of formula (I) eliminate more quickly from a living organism, as demonstrated by rat screening studies, than perfluoro alkanoic acids having 8 or more carbon atoms. Additionally, it has been found that these surfactants can be used in the emulsion polymerization of fluorinated monomers to produce fluoropolymer dispersions, wherein the surfactants can be recovered from the dispersions in an easy and convenient way.


Because of their lower bio-accumulation, the fluorinated surfactants, salts, and derivatives thereof (such as ester derivatives) should provide less of an environmental burden where 100% recovery of these surfactants from the dispersions is not achieved. Further, the process of reducing the amount of these surfactants in the dispersions should be more beneficial for operators of the removal processes, wherein the operators may be exposed, for example accidentally, to fluorinated carboxylic acids, their salts, or derivatives used in work-up procedures following the recovery of surfactants from the fluoropolymer dispersions.


In particular embodiments, fluorinated surfactants that contain no branched alkyl groups and no branched alkylene groups exhibit a more favorable bio-accumulation profile. That is, linear fluorinated surfactants tend to show a shorter renal elimination half-life and a higher rate of recovery than the corresponding branched fluorinated surfactants.


In some embodiments, the fluorinated surfactants are those that when administered to rats show a recovery of at least 45%, for example at least 50% of the administered amount after 96 hours via renal elimination and that have a renal elimination half-life of not more than 35 hours, for example of not more than 30 hours in rats as tested according to the method set forth in the examples. Generally, fluorinated surfactants in which each of the fluorinated aliphatic moieties in the compound have not more than 3 carbon atoms fulfill the aforementioned conditions of renal recovery and half-life. Thus, some embodiments include those fluorinated surfactants in which any fluorinated alkylene groups have not more than 3 carbon atoms and in which a fluorinated alkyl group of the compound has not more than 3 carbon atoms.


Generally, the fluorinated surfactant will be a low molecular weight compound, for example a compound having a molecular weight for the anion part of the compound of not more than 1000 g/mol, typically not more than 600 g/mol and in particular embodiments, the anion of the fluorinated surfactant (that is, the anion of the carboxylic acid) may have a molecular weight of not more than 500 g/mol.


In the above formula (I), L represents a linking group. The linking group may be an alkylene group, and can be a linear or branched and may be partially or fully fluorinated. Fully fluorinated alkylene groups include alkylene groups that consist of only carbon and fluorine atoms whereas partially fluorinated alkylene groups may additionally contain hydrogen. Generally, a partially fluorinated alkylene group should not contain more than 2 hydrogen atoms so as to be highly fluorinated and be non-telogenic or at least have minimal telogenic effects. Examples of fully fluorinated alkylene groups include linear perfluorinated alkylenes that have from 1 to 6 carbon atoms, for example linear perfluorinated alkylene groups of 1, 2, 3, 4 or 5 carbon atoms.


Examples of linear partially fluorinated alkylene groups include those that have from 1 to 6 carbon atoms. In a particular embodiment the linear partially fluorinated alkylene linking group has 1, 2, 3, 4, 5 or 6 carbon atoms and has only 1 or 2 hydrogen atoms. When the partially fluorinated alkylene group has 2 hydrogen atoms, the hydrogen atoms may be attached to the same carbon atom or they can be attached to different carbon atoms. When they are attached to different carbon atoms, such carbon atoms can be adjacent to each other or not. Also, in a particular embodiment, a carbon atom having 1 or 2 hydrogen atoms may be adjacent the ether oxygen atom to which the linking group is attached or adjacent the carboxylic group to which the linking group is attached at its other end.


Particular examples of linking groups L may be selected from the following:

  • —(CF2)g— wherein g is 1, 2, 3, 4, 5 or 6;
  • —CFH—(CF2)h— wherein h is 0, 1, 2, 3, 4 or 5;
  • —CF2—CFH—(CF2)d— wherein d is 0, 1, 2, 3 or 4;
  • —CH2—(CF2)h— wherein h is 1, 2, 3 or 4;
  • —(CH2)c— wherein c is 1, 2, 3 or 4;


    In the above examples, the left side of the formula of the linking group is the site where the linking group is connected to an ether oxygen in formula (I).


The Rf group in formula (I) represents a partially fluorinated alkyl group, a fully fluorinated alkyl group, a partially fluorinated alkyl group that is interrupted with one or more oxygen atoms, and a fully fluorinated alkyl group that is interrupted with one or more oxygen atoms.


In one embodiment, Rf is a linear perfluorinated aliphatic group having 1 to 6 carbon atoms, preferably having 1, 2, 3 or 4 carbon atoms. According to another embodiment Rf is a linear perfluorinated aliphatic group interrupted with one or more oxygen atoms of which the alkylene groups between oxygen atoms have not more than 4 or 6 carbon atoms, for example 3 or less carbon atoms and wherein the terminal alkyl group has not more than 4 or 6 carbon atoms, for example 3 or less carbon atoms.


According to a still further embodiment, Rf is a linear partially fluorinated aliphatic group having 1 to 6 carbon atoms and not more than 2 hydrogen atoms or a linear partially fluorinated aliphatic group interrupted with one or more oxygen atoms and which has not more than 2 hydrogen atoms. In the latter embodiment, it will generally be preferred that any perfluorinated alkylene moiety has not more than 4 or 6 carbon atoms and any terminal perfluorinated alkyl group, likewise preferably should not have more than 6 carbon atoms, for example not more than 4 carbon atoms. A particular example of a partially fluorinated aliphatic group Rf is CF3 CFH—.


Specific examples of compounds according to formula (I) include the following:

  • Rf—O—CHF—COOH
  • C3F7—O—CHF—COOH
  • CF3—O—CF2CF2—CF2—O—CHF—COOH
  • CF3CF2CF2—O—CF2CF2—CF2—O—CHF—COOH
  • CF3—O—CF2—CF2—O—CHF—COOH
  • CF3—O—CF2—O—CF2—CF2—O—CHF—COOH
  • CF3—(OCF2)2—O—CF2—CF2—O—CHF—COOH
  • CF3—(OCF2)3—O—CF2—CF2—O—CHF—COOH
  • Rf—O—CHF—CF2—COOH
  • CF3—O—CHF—CF2—COOH
  • CF3—O—CF2CF2—O—CHF—CF2—COOH
  • CF3—CF2—O—CHF—CF2—COOH
  • CF3—O—CF2CF2—CF2—O—CHF—CF2—COOH
  • CF3—O—CF2—O—CF2CF2—O—CHF—CF2—COOH
  • CF3—(OCF2)2—O—CF2CF2—O—CHF—CF2—COOH
  • CF3—(OCF2)3—O—CF2CF2—O—CHF—CF2—COOH
  • Rf—O—CF2—CHFCOOH
  • CF3—O—CF2—CHF—COOH
  • C3F7—O—CF2—CHF—COOH
  • CF3—O—CF2CF2CF2—O—CF2—CHF—COOH
  • CF3—O—CF2—O—CF2CF2—O—CF2—CHF—COOH
  • CF3—(OCF2)2—O—CF2CF2—O—CF2—CHF—COOH
  • CF3—(OCF2)3—O—CF2CF2—O—CF2—CHF—COOH
  • Rf—O—CF2—CHF—CF2COOH
  • CF3—O—CF2—CHF—CF2—COOH
  • C2F5—O—CF2—CHF—CF2—COOH
  • C3F7—O—CF2—CHF—CF2—COOH
  • CF3—O—CF2CF2CF2—O—CF2—CHF—CF2—COOH
  • CF3—O—CF2—O—CF2CF2—O—CF2—CHF—CF2—COOH
  • CF3—(OCF2)2—O—CF2CF2—O—CF2—CHF—CF2—COOH
  • CF3—(OCF2)3—O—CF2CF2—O—CF2—CHF—CF2—COOH
  • Rf—(O)m—CHF—CF2—O—(CH2)n—COOH n=1, 2 or 3; m=0 or 1
  • CF3—O—CHF—CF2—O—CH2—COOH
  • CF3—O—CF2CF2CF2—O—CHF—CF2—O—CH2—COOH
  • C3F7—O—CHF—CF2—O—CH2—COOH
  • C3F7—O—CHF—CF2—O—CH2CH2—COOH
  • C3F7—O—CF2CF2—O—CHF—CF2—OCH2—COOH
  • C3F7—O—CF2—CF2—CF2—O—CHF—CF2—OCH2—COOH
  • C3F7—O—CF2—CHF—CF2—OCH2—COOH
  • CF3—CHF—CF2—O—CH2—COOH
  • C3F7—CF2—CHF—CF2—OCH2—COOH
  • Rf—O—((CF2)n—O)m—CH2—COOH n=1, 2, or 3; m=0, 1, 2
  • CF3—O—CF2CF2—O—CH2—COOH
  • CF3—O—CF2CF2CF2—O—CF2CF2—O—CH2—COOH
  • C3F7—O—CF2CF2—O—CH2—COOH
  • C3F7—O—CF2CF2—O—CF2CF2—OCH2—COOH
  • C3F7—O—CF2CF2CF2—O—CF2CF2—OCH2—COOH
  • C3F7—O—CF2CF2CF2—OCH2—COOH
  • C4F9—O—CH2—COOH
  • C3F7—O—CH2—COOH
  • C6F13—OCH2—COOH
  • Rf—O—CF2CF2—COOH
  • CF3—O—CF2CF2—COOH
  • C2F5—O—CF2CF2—COOH
  • C3F7—O—CF2CF2—COOH
  • C4F9—O—CF2CF2—COOH
  • Rf—(OCF2)u—O—CF2—COOH where u is 1, 2, or 3
  • CF3—(OCF2)3—O—CF2—COOH
  • CF3—(OCF2)2—O—CF2—COOH
  • CF3—(OCF2)—O—CF2—COOH
  • Rf—(OCF2CF2)k—O—CF2—COOH with k being 1, 2 or 3
  • CF3—(OCF2CF2)1—O—CF2—COOH
  • C2F5—(OCF2CF2)1—O—CF2—COOH
  • C3F7—(OCF2CF2)1—O—CF2—COOH
  • C4F9—(OCF2CF2)1—O—CF2—COOH
  • C2F5—(OCF2CF2)2—O—CF2—COOH
  • CF3—(OCF2CF2)2—O—CF2—COOH
  • C3F7—(OCF2CF2)2—O—CF2—COOH
  • C4F9—(OCF2CF2)2—O—CF2—COOH
  • Rf—O—CF2—COOH
  • C3F7—O—CF2—COOH
  • CF3—O—CF2CF2CF2—O—CF2—COOH
  • CF3CHF—O—(CF2)o—COOH with o being an integer of 1, 2, 3, 4, 5 or 6
  • CF3 CFH—O—(CF2)3—COOH
  • CF3 CFH—O—(CF2)5—COOH
  • CF3CF2—O—(CF2)o—COOH with o being as above
  • CF3 CF2—O—(CF2)3—COOH
  • CF3 CF2—O—(CF2)5—COOH


Surfactants of formula (II) are commercially available from Anles Ltd., St. Petersburg, Russia. These compounds may be prepared, for example, as described by Ershov and Popova in Fluorine Notes 4(11), 2002. Also, these perfluoropolyethers typically form as byproducts in the manufacturing of hexafluoropropylene oxide by direct oxidation of hexafluoropropylene.


Surfactants according to formula (III) can be derived from reactants that are also used in the manufacturing of fluorinated vinyl ethers as described in U.S. Pat. No. 6,255,536. Accordingly, these perfluoropolyethers can be obtained in an economically attractive way as they can be derived from other starting materials that may be used as needed in the manufacturing of fluoromonomers and fluoropolymers.


Examples of compounds according to formula (II) or formula (III) include:


CF3—(OCF2)3—O—CF2COOH


CF3—(OCF2)2—O—CF2COOH


CF3—(OCF2)—O—CF2COOH


CF3—O—C3F6—O—CF2COOH


CF3—O—C3F6—O—CF(CF3)COOH


The surfactants of formula (IV) can be prepared by a number of routes including, for instance, reacting, generally in the presence of a base, (a) a fluorinated olefin of the general formula:

Rf1—(O)t—CF═CF2


wherein Rf1 and t are as defined above with (b) an organic compound of the formula:

(HO)n—R-G


wherein n is 1, 2 or 3, G and R are as defined above.


Other synthetic routes include those discussed, for instance, in co-pending application GB 0523853.0 of Koenigsmann et al.


Specific examples of surfactants according to formula (IV) include:


C3F7—O—CHF—CF2—OC6H4COOLi+


C3F7—O—CF2—CF2—O—CHF—CF2—OC6H4COONa+


C3F7—O—CF2—CF2—CF2—O—CHF—CF2—OC6H4COOH


C3F7—O—CF2—CHF—CF2—OC6H4COONH4+


C3F7—CF2—CHF—CF2—OC6H4COONH4+


C3F7—O—CHF—CF2—OCH2COOLi+


C3F7—O—CF2—CF2—O—CHF—CF2—OCH2COONa+


C3F7—O—CF2—CF2—CF2—O—CHF—CF2—OCH2COOH


C3F7—O—CF2—CHF—CF2—OCH2COONH4+


C3F7—CF2—CHF—CF2—OCH2COONH4+


CF3—CH(CF3)—CF2—O—CH2—COOH


C3F7—O—C(CF3)F—CF2—O—CFH—CF2—O—CH2—COOH


CF3—CFH—CF2—O—C6H4—COOH


Fluorinated surfactants of formula (V) can be derived from a fluorinated olefin of formula (VII).

Rf2—(O)s—CF═CF2  (VII)


Fluorinated olefins according to formula (VII) that can be used to prepare the fluorinated surfactants of formula (V) include perfluorinated alkyl vinyl compounds, vinyl ethers in particular perfluorovinyl ethers and allyl ethers, in particular perfluorinated allyl ethers. Particular examples of fluorinated olefins include those that are used in the preparation of fluoropolymers and that are described below.


According to one embodiment, surfactants according to formula (V) wherein n is 0 can be prepared by reacting a fluorinated olefin of formula (VII) with a base. The reaction is generally carried out in aqueous media. An organic solvent may be added to improve the solubility of the fluorinated olefin. Examples of organic solvents include glyme, tetrahydrofuran (THF) and acetonitrile. Additionally or alternatively a phase transfer catalyst may be used. As a base, use can be made of for example ammonia, alkali and earth alkali hydroxides. Without intending to be bound by any theory, it is believed, that the reaction proceeds according to the following sequence when ammonia is used as a base:

Rf2—(O)s—CF═CF2+NH3+H2O→Rf2—(O)s—CHF—COONH4+NH4F


The reaction is generally carried out between 0 and 200° C., for example between 20150° C. and at a pressure between about 1 bar up to about 20 bar. For further purification, the obtained salts can be distilled via the free acid or by first converting the acid into an ester derivative and then distilling the ester derivative followed by hydrolysis of the ester to obtain the purified acid or salt thereof.


In an alternative embodiment to prepare the fluorinated surfactants of formula (V) wherein n is 0 can be prepared by reacting a fluorinated olefin of formula (VII) with a hydrocarbon alcohol in an alkaline medium and then decomposing the resulting ether in acidic conditions thereby forming the corresponding carboxylic acid. Suitable hydrocarbon alcohols include aliphatic alcohols such as those having 1 to 4 carbon atoms. Specific examples include methanol, ethanol and butanol including t-butanol. The reaction of the fluorinated olefin with the alcohol in an alkaline medium may be carried out as described in Furin et al., Bull Korean Chem. Soc. (20), 220 (1999). The reaction product of this reaction is an ether derivative of the fluorinated olefin. This resulting ether can be decomposed under acidic conditions as described in D. C. England, J. Org. Chem. (49), 4007 (1984) to yield the corresponding carboxylic acid or salt thereof.


To prepare fluorinated surfactants of formula (V) wherein n is 1, a free radical reaction of the fluorinated olefin of formula (VII) with a hydrocarbon alcohol may be carried out followed by an oxidation of the resulting reaction product. Suitable hydrocarbon alcohols that can be used include aliphatic alcohols such as lower alkanols having 1 to 4 carbon atoms. Specific examples include methanol, ethanol and propanol. The free radical reaction is typically carried out using a free radical initiator as is typically used in a free radical polymerization reaction. Examples of suitable free radical initiators include persulfates such as for example ammonium persulfate. Detailed conditions of the free radical reaction of the fluorinated surfactant with an alcohol can be found in S. V. Sokolov et al., Zh. Vses. Khim Obsh (24), 656 (1979). The resulting alcohol derivative of the fluorinated olefin can be chemically oxidized with an oxidizing agent to the corresponding carboxylic acid. Examples of oxidizing agents include for example potassium permanganate, chromium (VII) oxide, RuO4 or OsO4 optionally in the presence of NaOCl, nitric acid/iron catalyst, dinitrogen tetroxide. Typically the oxidation is carried out in acidic or basic conditions at a temperature between 10 and 100° C. In addition to chemical oxidation, electrochemical oxidation may be used as well.


Specific examples of fluorinated surfactants according to formula (V) include:

  • CF3—O—CF(CF3)—CF2—O—CHF—COOH
  • C3F7—O—CHF—COOH
  • C3F7—O—CF(CF3)—CF2—O—CHF—COOH
  • CF3—O—CF2CF2—CF2—O—CHF—COOH
  • CF3—O—CF2—CF2—O—CHF—COOH
  • CF3—O—CHF—CF2—COOH
  • CF3—O—CF2—CF2—O—CHF—CF2—COOH
  • CF3—CF2—CHF—CF2—COOH
  • CF3—O—CF2—CF2—CF2—O—CF2—CHF—COOH
  • CF3—O—CF2—CF2—CF2—O—CF2—CHF—CF2—COOH


The surfactants according to formula (VI) can be synthesized starting from the corresponding perfluorinated acid fluorides, the preparation of which is described e.g. in WO 01/46116. To prepare a surfactant of formula (VI) in which X is a carboxylic acid, the corresponding perfluorinated acid fluorides are hydrolyzed with water. Conversion of the acid to any salt may be accomplished by neutralization with an appropriate base. Alternatively, the perfluorinated acid fluoride may be reacted with an alcohol (e.g. methanol or ethanol) so as to result in the corresponding ester. This ester can then be distilled for further purification and finally be saponified to the desired salt.


Specific examples of surfactants according to formula (VI) include:


CF3—O—CF2CF2—COOM


CF3CF2—O—CF2CF2COOM


CF3CF2CF2—O—CF2CF2COOM


(CF3)2CF—O—CF2CF2COOM


(CF3)3C—O—CF2CF2COOM


CF3(CF2)3—O—CF2CF2—COOM


wherein M represents H, Na, K or NH4.


It is understood that while the description of compounds in the present application may reference only the acid form or only the salt form of a certain species, the corresponding acids and salts, in particular the NH4+, potassium, sodium or lithium salts, can equally be used.


The fluorinated liquid may, for instance, be selected from aliphatic and aromatic fluorinated liquids that optionally have oxygen, sulfur and/or nitrogen atoms. In particular, some embodiments have up to 2 oxygen, sulfur and/or nitrogen atoms.


The fluorinated liquid typically will have a boiling point of at least 30° C., at least 100° C., or even at least 150° C., for example between 150° C. and 230° C. Fluorinated liquids with boiling points above 230° C. are also contemplated. For instance, fluorinated liquids may have boiling points up to 250° C., up to 300° C., even up to 350° C.


In a particular embodiment the fluorinated liquid is capable of participating in the free radical polymerization reaction such that the fluorinated liquid is incorporated into the fluoropolymer structure produced. That is, in some embodiments, the fluorinated liquid is polymerizable. A polymerizable fluorinated liquid may, in some embodiments, have the advantage that little if any residual of the fluorinated liquid will remain in the aqueous dispersion. Examples of fluorinated liquids capable of participating in the polymerization (i.e., polymerizable) include, in particular, liquid monomers such as, for instance, liquid fluorinated monomers. Examples of liquid fluorinated monomers that can be used include liquid perfluorovinyl ethers such as perfluoro-2-propoxypropylvinyl ether, perfluoro-3-methoxy-n-propylvinyl ether and CF3—(CF2)2—O—CF(CF3)—CF2—O—CF(CF3)—CF2—O—CF═CF2 (PPVE-3).


Suitable fluorinated liquids include those selected from perfluoroalkanes and (Rf′)3N, wherein each Rf′ is independently selected from a fluorinated alkyl group having from 1 to 10 carbon atoms.


In other embodiments, the fluorinated liquid may be selected from perfluoropolyethers of formula (VIII):

Rf″—(OCF2)x—(OCF2CF2)y—(CF(CF3)—CF2)z—(OCF(CF3))a-Q  (VIII)

In formula (VIII), Rf″ is selected from perfluoroalkyl groups having from 1 to 10 carbon atoms; Q is selected from Rf″ and Rf″ —(OCF2)x—(OCF2CF2)y—(CF(CF3)—CF2)z—(OCF(CF3))a; each x, y, z, and a is independently selected from 0 to 10, with the proviso that the sum of x+y+z+a is at least 1.


In yet further embodiments, the fluorinated liquid may be a partially fluorinated liquid. It is preferred, however, that a partially fluorinated liquid does not act as a chain transfer agent in the aqueous phase. Chain transfer agents are non-radical species that react with a radical species. This may involve, for instance, a chain transfer agent reacting with an actively polymerizing chain. The result of this reaction is at least one different radical species. After this happens, the polymerizing chain is terminated. A new chain may or may not start, depending on the reactivity of the new radical species. In many cases, the result is a diminution of the molecular weight of the resulting polymer compared with a polymer prepared under the same conditions except that the chain transfer agent is not present. This diminution of molecular weight often takes place without a change in the overall rate of conversion of monomer to polymer. Therefore, it is possible to determine whether a fluorinated liquid is acting as a chain transfer agent in the aqueous phase by observing the molecular weight of the resulting polymer with and without the fluorinated liquid. If the molecular weight is significantly decreased with the addition of the fluorinated liquid (e.g., by 10% or more, by 20% or more, or even by 30% or more), then the fluorinated liquid is acting as a chain transfer agent in the aqueous phase.


Particular embodiments of partially fluorinated liquids include those selected from fluorinated polyethers of the formula (IX):

Rf″″—[OC3F6]n—O—CHFCF3  (IX)

wherein Rf″″ is selected from a perfluorinated alkyl group having from 1 to 4 carbon atoms, and n is from 1 to 10.


Other embodiments of partially fluorinated liquids include those selected from fluorinated polyethers of formula (X):

Rf′″—O—CFH—CF2—O—R  (X)

In formula (X), Rf′″ may be selected from a perfluorinated alkyl group having from 1 to 10 carbon atoms and R may be selected from CH3 and Rf′″, wherein when R is Rf′″, it may be the same or different than the other Rf′″.


In yet other embodiments, fluorinated liquids include perfluorinated hydrocarbons such as, for instance, perfluorinated saturated aliphatic compounds such as a perfluorinated alkane; a perfluorinated aromatic compound such as perfluorinated benzene, or perfluorinated tetradecahydrophenanthene. Perfluorinated liquids also include perfluorinated alkyl amines such as a perfluorinated trialkyl amine. Furthermore, the perfluorinated liquid may be a perfluorinated cyclic aliphatic, such as decalin; and preferably a heterocyclic aliphatic compound containing oxygen, nitrogen or sulfur in the ring, such as perfluorinated N-alkyl substituted morpholines or perfluoro-2-butyl tetrahydrofuran. Other embodiments include perfluoropolyethers such as, for instance, those available under the trade names Galden™, Fomblin™ (available from Solvay Solexis); Demnum™ SH (available from Daikin); and Krytox™ (available from DuPont).


Specific examples of perfluorinated hydrocarbons include perfluoro-2-butyltetrahydrofuran, perfluorodecalin, perfluoromethyldecalin, perfluoromethyldecalin, perfluoromethylcyclohexane, perfluoro(1,3-dimethylcyclohexane), perfluorodimethyldecahydronaphthalene, perfluoro(tetradecahydrophenanthrene), perfluorotetracosane, perfluorokerosenes, oligomers of poly(chlorotrifluoroethylene), perfluoro(trialkylamine) such as perfluoro(tripropylamine), perfluoro(tributylamine), or perfluoro(tripentylamine), and octafluorotoluene, hexafluorobenzene, and commercial fluorinated solvents, such as Fluorinert FC-75, FC-72, FC-84, FC-77, FC-40, FC-43, FC-70 or FC 5312 all available from 3M Company, Saint Paul, Minn. The fluorinated alkanes can be linear or branched, with a carbon atom number between 3 and 20.


In some embodiments, the polymerization is carried out in the presence of an aqueous mixture, where the aqueous mixture, prior to addition to the polymerization medium, is in the form of a micro-emulsion.


Micro-emulsions are generally characterized by being thermodynamically stable and having a particle size of from about 5 to 50 nm. See, for instance, Applied Surfactants, Tadros, Tharwat F., Chapter 10 (2005). They are obtainable though any technique known to produce micro-emulsions, such as heating a mixture of concentrated surfactant solution (e.g., the concentration of surfactant is greater than the critical micelle concentration for the surfactant) and a fluorinated liquid until the mixture is transparent. The mixture is then cooled. This micro-emulsion can then be added to the polymerization process as described generally herein. In this embodiment, the fluorinated surfactant-fluorinated liquid mixture may or may not remain as a micro-emulsion after it is added to the polymerization reactor.


In this embodiment, upon addition to the polymerization reactor, the amount of fluorinated liquid in the aqueous phase of the emulsion polymerization may be, for instance, not more than 1% by weight based on the aqueous phase.


Generally, the amount of fluorinated liquid in such embodiments will be not more than 0.5% by weight, not more than 0.2% by weight, or even less than 0.1% by weight. Even amounts of not more than 0.01% by weight have been found to produce meritorious effects in the aqueous emulsion polymerization.


The fluorinated surfactant concentration in the aqueous dispersion may be, for instance, up to 1% by weight, 0.01 to 1% by weight, or even 0.005% to 0.4% based on the weight of the aqueous dispersion.


Part or all of the fluorinated surfactant used in the aqueous emulsion polymerization may be added as a mixture with fluorinated liquid. Generally at least 5% by weight, preferably at least 10% by weight of the total amount of fluorinated surfactant used will be added in the form of a mixture with the fluorinated liquid. If only part of the fluorinated surfactant is added under the form of a mixture with fluorinated liquid, the remainder of the fluorinated surfactant may be added separately to the aqueous phase, e.g. prior to the addition of the mixture of fluorinated surfactant and fluorinated liquid.


In another embodiment, the aqueous mixture is an emulsion that contains a polymerizable fluorinated liquid, along with the fluorinated surfactant. In such embodiments, the amount of fluorinated liquid in the aqueous mixture is 70% or less by weight based on the total weight of the aqueous mixture. For instance, 60% or less, 50% or less, or even 40% or less. The fluorinated liquid may be present in the aqueous mixture in an amount of 1% or greater, 5% or greater, 10% or greater, even 20% or greater.


The fluorinated liquid is mixed with the aqueous solution of the fluorinated surfactant and is emulsified therein such that droplets having an average droplet diameter of not more than 2000 nm, preferably from 50 to 1500 nm, more preferably from 100 to 1300 nm are obtained.


Emulsions containing particles having an average droplet diameter of from 50 to 500 nm can be obtained by any suitable emulsifying apparatus such as those available from the company Microfluidics (Newton, Mass.).


Emulsions containing particle having an average droplet diameter of from 500 nm and higher, for instance, from 500 to 2000 nm, can be obtained using an Ultra Turrax™ high-shear mixer.


Aqueous mixtures may be added to an aqueous emulsion polymerization reaction in any manner that is convenient. For instance, the entire amount of the aqueous mixture may be added before the initiation of polymerization, it may be added during polymerization, or may be added in part before the initiation of polymerization, with the remainder of the mixture being added during polymerization.


The mixture of the fluorinated surfactant and fluorinated liquid may further be obtained by a predetermined contamination with the fluorinated liquid of the solid, or liquid fluorinated surfactant or molded acid or ester derivative of the fluorinated surfactant. For example, the process of contamination may involve re-crystallization of the surfactant.


Still further, a mixture of fluorinated surfactant and fluorinated liquid can be prepared in the preparation of the fluorinated surfactant. For example, the corresponding acid of the fluorinated surfactants according to formulae (II)-(VI) may be distilled in the presence of the fluorinated liquid. Subsequently the acid may be converted into its salt form, for example by adding ammonia if an ammonium salt is desired. The fluorinated liquid may for example be added to the corresponding acid of the fluorinated surfactant and the mixture may then be distilled which will result in the distillate containing a mixture of acid and fluorinated liquid.


The aqueous mixture of the fluorinated surfactant and fluorinated liquid can then be obtained by converting the contaminated fluorinated surfactants or acid or ester derivatives to the salts, and adding to water.


The methods described herein may have aqueous phases that further comprise a second fluorinated surfactant, which may be any fluorinated surfactant known for use in aqueous emulsion polymerization of fluorinated monomers. Particularly, the aqueous phase may comprise fluorinated surfactants including those according to formula (XI):

Y—Rf—Z-M  (XI)

In formula (XI), Y represents hydrogen, Cl or F; Rf represents a linear or branched perfluorinated alkylene having 4 to 10 carbon atoms; Z represents COO or SO3 and M represents a monovalent cation such as for example an alkali metal ion or an ammonium ion. Mixtures of second fluorinated surfactants can also be used. In one embodiment, the second fluorinated surfactant is an ammonium or metal salt of perfluorooctanoic acid or perfluorooctanesulphonic acid. In certain embodiments, when a second fluorinated surfactant of formula (X) is present, the fluorinated surfactant may be selected from perfluorinated mono-ether carboxylic acids and partially fluorinated ether carboxylic acids (including mono- and poly-ether carboxylic acids).


In yet another embodiment, the polymerization itself can be carried out in a micro-emulsion. That is, when the polymerizing is carried out in the presence of a fluorinated surfactant and a fluorinated liquid, the fluorinated surfactant and fluorinated liquid are in the form of a micro-emulsion.


The aqueous emulsion polymerization process is generally conducted under commonly employed conditions. Polymerization temperatures may range from 0 to 150° C., from 10 to 100° C., or from 30° C. to 80° C. The total pressure of the headspace in the reactor may be kept at any pressure, for instance, from 4 to 30 bar, or from 8 to 20 bar.


The aqueous emulsion polymerization process can be used to produce any of the known fluoropolymers, i.e. polymers that have a partially or fully fluorinated backbone. In particular, the aqueous emulsion polymerization process can be used to produce homo- and copolymers of gaseous fluorinated olefinic monomers such as tetrafluoroethylene, vinylidene fluoride and chlorotrifluoroethylene. Suitable comonomers include fluorinated monomers such as hexafluoropropene, perfluoro vinyl ethers including perfluoroalkyl vinyl ethers such as perfluoromethyl vinyl ether and perfluoro-n-propylvinyl ether and perfluoroalkoxy vinyl ethers such as those corresponding to formula (XII):

CF2═CFO(R1O)n(R2O)mR3  (XII)

wherein R1 and R2 are each independently selected from a linear or branched perfluoroalkylene group having from 2 to 6 carbon atoms, m and n are each independently from 0 to 10, with the proviso that the sum of n and m is at least 1, and R3 is a perfluoroalkyl group of from 1 to 6 carbon atoms. Combinations of any of the above-named fluorinated monomers are also contemplated.


Further particular monomers include, for instance, CF2═CF—O—(CF2)4—SO2F (MV4S); CF2═CF—O—(CF2)5CN (MV5CN); CF2═CFCF2—O—(CF2)n—O—CF3 where n is 1 to 5 (MA“n”1, for instance, MA31 corresponds to n=3); and CF2═CF—O—(CF2)n—O—CF3 where n is 1 to 5 (MV“n”1, for instance, MV31 corresponds to n=3).


Non-fluorinated monomers that can be used as comonomers include alpha-olefins, e.g. ethylene and propylene. The process of the invention can be used to produce fluoroelastomers as well as fluorothermoplasts.


The aqueous emulsion polymerization is typically initiated by an initiator including any of the initiators known for initiating a free radical polymerization of fluorinated monomers. Suitable initiators include peroxides and azo compounds and redox based initiators. Specific examples of peroxide initiators include, hydrogen peroxide, sodium or barium peroxide, diacylperoxides such as diacetylperoxide, disuccinoyl peroxide, dipropionylperoxide, dibutyrylperoxide, diglutaric acid peroxide, and further per-acids and salts thereof such as e.g. ammonium, sodium or potassium salts. Examples of per-acids include peracetic acid. Esters of the peracid can be used as well. Examples of inorganic initiators include for example ammonium- alkali- or earth alkali salts of persulfates, permanganic or manganic acid or manganic acids.


A persulfate initiator, e.g. ammonium persulfate (APS), may be used alone or may be used in combination with a reducing agent. Suitable reducing agents include bisulfites such as for example ammonium bisulfite or sodium metabisulfite, thiosulfates such as for example ammonium, potassium or sodium thiosulfate, hydrazines, azodicarboxylates and azodicarboxyldiamide (ADA). Further reducing agents that may be used include sodium formaldehyde sulfoxylate (Rongalit®, available from BASF, Germany) or fluoroalkyl sulfinates. The reducing agent typically reduces the half-life time of the persulfate initiator. Additionally, a metal salt catalyst such as for example copper, iron or silver salts may be added.


The aqueous emulsion polymerization system may further comprise other materials, such as buffers and, if desired, complex-formers or chain-transfer agents.


The achievable solids content of the polymer dispersion is typically from 5 to 40% without any major coagulum. The resultant dispersions are highly stable and generally have an number average particle diameter of not more than 400 nm, typically between 50 and 350 nm average particle sizes can be achieved.


The fluoropolymer may be isolated from the dispersion by coagulation if a polymer in solid form is desired. Also, depending on the requirements of the application in which the fluoropolymer is to be used, the fluoropolymer may be post-fluorinated so as to convert any thermally unstable end groups into stable CF3 end groups. Generally, when the fluoropolymer is post fluorinated, it is post fluorinated such that the amount of end groups in the fluoropolymer other than CF3 is less than 80 per million carbon atoms.


For coating applications, an aqueous dispersion of the fluoropolymer may be desired and hence the fluoropolymer may not need to be separated or coagulated from the dispersion. To obtain a fluoropolymer dispersion for use in coating applications such as, for example, in the impregnation of fabrics or in the coating of metal substrates to make for example cookware, further stabilizing surfactants may be added and/or the level of fluoropolymer solids may be increased. For example, non-ionic stabilizing surfactants may be added to the fluoropolymer dispersion. Typically these will be added to an aqueous fluoropolymer dispersion in an amount of 1 to 12% by weight based on fluoropolymer solids. Examples of non-ionic surfactants that may be added include:

R1—O—[CH2CH2O]n—[R2O]m—R3  (XIII)

wherein R1 represents an aromatic or aliphatic hydrocarbon group having at least 8 carbon atoms, R2 represents an alkylene having 3 carbon atoms, R3 represents hydrogen or a C1-C3 alkyl group, n has a value of 0 to 40, m has a value of 0 to 40 and the sum of n+m being at least 2. It will be understood that in the above formula (XIII), the units indexed by n and m may appear as blocks or they may be present in an alternating or random configuration. Examples of non-ionic surfactants according to formula (XIII) above include alkylphenol oxy ethylates such as ethoxylated p-isooctylphenol commercially available under the brand name TRITON™ such as for example TRITON™ X 100 wherein the number of ethoxy units is about 10 or TRITON™ X 114 (available from Dow Chemical, Midland, Mich.) wherein the number of ethoxy units is about 7 to 8. Still further examples include those in which R1 in the above formula (XII) represents an alkyl group of 4 to 20 carbon atoms, m is 0 and R3 is hydrogen. An example thereof includes isotridecanol ethoxylated with about 8 ethoxy groups and which is commercially available as GENAPOL®X080 (available from Clariant GmbH, Germany). Non-ionic surfactants according to formula (XII) in which the hydrophilic part comprises a block-copolymer of ethoxy groups and propoxy groups may be used as well. Such non-ionic surfactants are commercially available from Clariant GmbH under the trade designation GENAPOL® PF 40 and GENAPOL® PF 80.


The amount of fluoropolymer solids in the dispersion may be up-concentrated as needed or desired to an amount between 30 and 70% by weight. Any of the known up-concentration techniques may be used including ultra-filtration and thermal up-concentration.


In some embodiments the surfactant may be removed or reduced from fluoropolymer dispersions described herein. The methods for removal include those generally known in the art including those described in U.S. Pat. No. 6,833,403, Blädel, et al.


Applications for the fluoropolymers and fluoropolymer dispersions made from the processes described herein include those commonly known for fluoropolymers. These applications include, for instance, those described in Fluoroplastics: Vol. 1, Non-Melt Processible Fluoroplastics, Ebnesajjad, Chapter 17 (2000) and Fluoroplastics: Vol. 2, Melt Processible Fluoropolymers, Ebnesajjad, Parts II and III (2003).


Advantages and embodiments of this invention are further illustrated by the following examples, but the particular materials and amounts thereof recited in these examples, as well as other conditions and details, should not be construed to unduly limit this invention. All parts and percentages are by weight unless otherwise indicated.


EXAMPLES
Test Methods

Particle Size


The latex particle size determination was conducted by means of dynamic light scattering with a Malvern Zetasizer 1000 HAS in accordance to ISO/DIS 13321. Prior to the measurements, the polymer latexes as yielded from the polymerizations were diluted with 0.001 mol/L KCl-solution, the measurement temperature was 25° C. in all cases. The reported average is the Z-average particle diameter.


SSG


Standard specific gravity was measured according ASTM 4895-04


Solid Content


Determination of solid content was done by subjecting the latex sample to a temperature up to 250° C. for 30 min.


Hexafluoropropylene (HFP) Content


The HFP content was measured via FTIR-spectroscopy as described in U.S. Pat. No. 4,552,925. The absorbances, A, at the wave-numbers of 980 cm and 2350 cm (A980 and A2350 respectively), were measured using a film of 0.05+0.01 mm in thickness with a Nicolet Magna 560 FTIR spectrometer. The HFP content was calculated according to the following equation:

HFP content(weight percent)=A980/A2350*3.2


Example 1
Preparation of Emulsifier

800 g of perfluoro-3,5,7,9-tetraoxadecanoic acid (CF3—(OCF2)4—COOH) (hereinafter Compound I) available from Anles Trade (Russia) and 1754 g of deionized water were introduced into a glass vessel equipped with a mechanical stirrer and a condenser. 150 g of an aqueous ammonia solution (25% by weight) was added dropwise to the mixture over a period of about 2 hours under stirring. The final clear and colorless solution had a pH of about 8.


Example 2
Preparation of a Microemulsion

392 g of ammonium salt of Example 1 and 8 g of Fluoroinert FC-70, available from 3M Company, Saint Paul, Minn., was introduced into a glass vessel equipped with a mechanical stirrer and a reflux condenser. The resulting dispersion was heated to 83° C. under mild stirring for about 8 hours and cooled to room temperature. A perfectly limpid solution containing 2% by weight (confirmed by gas chromatographic analysis) of the Fluoroinert was obtained.


Example 3
Comparative Example

The polymerization experiments were performed in a 40 liter kettle equipped with an impeller agitator and a baffle. The kettle was charged with 30 liters of deionized water and set to 35° C. The kettle was evacuated repeatedly and pressurized with nitrogen to remove oxygen. The agitator speed was set to 165 rpm. The oxygen-free kettle was charged with 70 mmol of fluorinated emulsifier from Example 1 and the following materials were added: 1.06 ml of a solution containing 40 mg of copper sulfate pentahydrate and 1 mg of concentrated sulfuric acid; 15 g of a 25 weight % aqueous ammonia solution and 5.5 g of PPVE-2. Finally, the reactor was pressurized with tetrafluoroethylene (TFE) to 0.2 MPa and 47 g of hexafluoropropylene (HFP) were added. The kettle was then set to 1.5 MPa by pressurizing with TFE. To start the polymerization, 20 ml of a an aqueous initiator solution containing 140 mg of sodium sulfite followed by 20 ml of a solution containing 340 mg of ammonium peroxodisulfate were pumped into the reactor. The beginning of the polymerization was indicated by a pressure drop. During polymerization, the pressure was maintained at 1.5 MPa by continuously feeding TFE into the kettle. After 3.2 kg of TFE had been added, the TFE inlet valve was closed and the pressure was released.


1000 ml of this polymer dispersion was coagulated by adding 20 ml of concentrated hydrochloric acid under agitation. The coagulated material was agglomerated with gasoline and washed repeatedly. The agglomerated polymer was dried overnight at 200° C. in a vacuum oven. Polymerization data and product characteristics are given in table 2.


Example 4

Example 4 was carried out as in Comparative Example 3, except that 70 mmol of emulsifier containing 2 weight % of Fluoroinert FC-70 as described in Example 2 was added to the kettle instead of the 90 mmol of fluorinated emulsifier described in Comparative Example 3.












TABLE 1







Example 3




(Comparative)
Example 4




















Polymerization time
91
101



(min)



Average Particle
110
72



Size (nm)



SSG (g/cm3)
2.171
2.189



Solid Content (wt %)
10.1
10.1



HFP Content
0.28
0.26



(% m/m)



pH
9.5
9.6











Determination of Bio-Accumulation


The fluorinated surfactants were evaluated for urinary clearance using a pharmacokinetic study in rats. The goal was to measure the total amount of parent compound eliminated via urinary output and estimate the rate of elimination. The study was approved by the IACUC (Institutional Animal Care and Use Committees) and was performed in 3M Company's AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care)-accredited facility.


The study utilized male Sprague Dawley rats, 6 to 8 weeks of age, and approximately 200 to 250 g body weight at study onset. The test compounds of table 2 were administered at a dose of 73 micromoles per kg body weight in rats (N=3 animals per tested compound). All test compounds were prepared in sterile deionized water and given to rats via oral gavage. After test compounds administration, the rats were housed individually in metabolism cages for urine collection: 0 to 6 hours, 6 to 24 hours, 24 to 48 hours and 72 to 96 hours. Animals were observed throughout the study for clinical signs of toxicity. Gross necropsy was performed at the termination of each study (96 hours post-dose) with sera and liver samples being retained from each animal


The concentration of the parent compound or metabolites thereof were quantitatively measured via fluorine NMR on each urine sample for each animal at each time point based on internally added standards.


The bioaccumulation data obtained in accordance with the above test are reported in table 3.













TABLE 3








% Recovery
Compound-related



T½ (h)
(96 h)
Effects



















C7F15COONH4
~550
6
Hepatomegaly


Compound 1
15
50






* T1/2 is the time required for the amount of a particular substance in a biological system to be reduced by one half by biological processes when the rate of removal is approximately exponential. In these examples the value of T1/2 is calculated by exponential least squares curve fitting (y = AeBx and T1/2 = 0.693/B) where y represents the concentration of analyte in urine and x represents time in hours.





Claims
  • 1. A method of making a fluoropolymer comprising polymerizing one or more fluorinated monomers in an aqueous emulsion polymerization in the presence of a fluorinated surfactant selected from fluorinated surfactants of formula (V) Rf2—(O)CHF—(CF2)—X  (V)
  • 2. The method of claim 1 wherein the fluorinated liquid is perfluorinated.
  • 3. The method of claim 1, wherein the fluorinated liquid is selected from the group consisting of a perfluoroalkane; a perfluorinated N-alkyl substituted morpholine; (Rf′)3N, wherein each Rf′is independently selected from a fluorinated alkyl group having from 1 to 10 carbon atoms; and combinations thereof.
  • 4. The method of claim 1 wherein the fluorinated liquid is selected from perfluoropolyethers of formula (VIII): Rf″—(OCF2)x—(OCF2CF2)y—(CF(CF3)—CF2)z—(OCF(CF3))a-Q  (VIII)
  • 5. The method of claim 1 wherein the fluorinated liquid is selected from fluorinated polyethers of formula (X): Rf′″—O—CFH—CF2—O—R  (X)
  • 6. The method of claim 1 wherein the fluorinated liquid is selected from fluorinated polyethers of the formula (IX): Rf″″—[OC3F6]n—O—CHFCF3  (IX)
  • 7. The method of claim 1 wherein the fluorinated liquid has a boiling point of at least 100° C.
  • 8. The method of claim 1 wherein the amount of fluorinated surfactant is not more than 1.0% by weight based on the weight of the aqueous mixture.
  • 9. The method of claim 1 wherein the aqueous phase further comprises a second fluorinated surfactant corresponds to the following general formula (XI): Y—RF—Z—M  (XI)
  • 10. The method of claim 1 wherein the amount of the fluorinated liquid in the aqueous mixture is between 0.1 and 70% by weight relative to the total weight of the aqueous mixture.
  • 11. The method of claim 1 wherein the anion of the fluorinated surfactant has a molecular weight of not more than 1000 grams per mole.
  • 12. The method of claim 1 wherein the fluorinated surfactant, when administered to a rat, has a renal recovery rate of at least 50% of the administered amount 96hours after administration and further wherein the renal half-life is not more than 30 hours.
  • 13. The method of claim 1 wherein the amount of fluorinated surfactant is from 1 to 40% by weight based on the weight of the aqueous mixture.
  • 14. The method of claim 1 wherein the fluorinated surfactant forms a microemulsion with the non-polymerizable fluorinated liquid.
  • 15. The method of claim 1 wherein the aqueous mixture comprises droplets having an average particle size of from 5 to 2000 nm.
  • 16. The method of claim 1 wherein the amount of fluorinated surfactant is less than 1% by weight based on the weight of the aqueous dispersion.
Priority Claims (4)
Number Date Country Kind
0514387.0 Jul 2005 GB national
0514398.7 Jul 2005 GB national
0523853.0 Nov 2005 GB national
0525978.3 Dec 2005 GB national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 11/457,239, filed on Jul. 13, 2006 now abandoned, which claims priority from Great Britain Application No. 0525978.3, filed on Dec. 21, 2005; Great Britain Application No. 0523853.0, filed on Nov. 24, 2005; Great Britain Application No. 0514398.7, filed on Jul. 15, 2005; and Great Britain Application No. 0514387.0 filed on Jul. 15, 2005, all of which are herein incorporated by reference in their entirety.

US Referenced Citations (273)
Number Name Date Kind
2516127 Lauer et al. Jul 1950 A
2534058 Renfrew Dec 1950 A
2559749 Benning Jul 1951 A
2559752 Berry Jul 1951 A
2713593 Brice et al. Jul 1955 A
3037953 Marks et al. Jun 1962 A
3142665 Cardinal et al. Jul 1964 A
3179614 Edwards Apr 1965 A
3260691 Lavin et al. Jul 1966 A
3271341 Garrison Sep 1966 A
3315201 Werme Apr 1967 A
3316201 Hahn et al. Apr 1967 A
3345317 Hoashi Oct 1967 A
3391099 Punderson Jul 1968 A
3451908 Sianesi et al. Jun 1969 A
3489595 Brown, Jr. Jan 1970 A
3555100 Garth et al. Jan 1971 A
3635926 Gresham et al. Jan 1972 A
3642742 Carlson Feb 1972 A
3721696 Sianesi et al. Mar 1973 A
3790403 Ribbans, III Feb 1974 A
3816524 Brinstead Jun 1974 A
3855191 Doughty, Jr. et al. Dec 1974 A
3882153 Seki et al. May 1975 A
3981945 Attwood et al. Sep 1976 A
3997599 Grinstead Dec 1976 A
4005137 Rudolph et al. Jan 1977 A
4010156 Nudelman et al. Mar 1977 A
4016345 Holmes Apr 1977 A
4025709 Blaise et al. May 1977 A
4049681 Dietrich et al. Sep 1977 A
4049863 Vassiliou Sep 1977 A
4060535 Cinco Nov 1977 A
4089804 Falk May 1978 A
4123401 Berghmans et al. Oct 1978 A
4131711 Attwood Dec 1978 A
4138373 Ukihashi et al. Feb 1979 A
4180609 Vassiliou Dec 1979 A
4252859 Concannon et al. Feb 1981 A
4262101 Hartwimmer et al. Apr 1981 A
4282162 Kuhls Aug 1981 A
4287112 Berghmans Sep 1981 A
4292402 Pollet et al. Sep 1981 A
4320205 Asawa et al. Mar 1982 A
4342825 Van Poucke et al. Aug 1982 A
4353950 Vassiliou Oct 1982 A
4369266 Kuhls et al. Jan 1983 A
4380618 Khan et al. Apr 1983 A
4381384 Khan Apr 1983 A
4391940 Kuhls et al. Jul 1983 A
4425448 Concannon et al. Jan 1984 A
4439385 Kuhls et al. Mar 1984 A
4499249 Nakagawa et al. Feb 1985 A
4544458 Grot et al. Oct 1985 A
4548986 Suzuki et al. Oct 1985 A
4552925 Nakagawa et al. Nov 1985 A
4588796 Wheland May 1986 A
4603118 Staab Jul 1986 A
4605773 Maloney et al. Aug 1986 A
4618641 Hengel Oct 1986 A
4621116 Morgan Nov 1986 A
4623487 Cope Nov 1986 A
4639337 Cope et al. Jan 1987 A
4766190 Morita et al. Aug 1988 A
4777304 Schweighardt Oct 1988 A
4789717 Giannetti et al. Dec 1988 A
4832879 Hamprecht May 1989 A
4847135 Braus et al. Jul 1989 A
4861845 Slocum et al. Aug 1989 A
4864006 Giannetti et al. Sep 1989 A
4925709 Shmueli May 1990 A
4987254 Schwertfeger et al. Jan 1991 A
5017480 Mori et al. May 1991 A
5068043 Thigpen et al. Nov 1991 A
5075397 Tonelli et al. Dec 1991 A
5090613 Lee Feb 1992 A
5153322 Flynn Oct 1992 A
5160791 Tannenbaum Nov 1992 A
5168107 Tannenbaum Dec 1992 A
5182342 Feiring et al. Jan 1993 A
5198491 Honda et al. Mar 1993 A
5219910 Stahl et al. Jun 1993 A
5223343 Tannenbaum Jun 1993 A
5229480 Uschold Jul 1993 A
5230961 Tannenbaum Jul 1993 A
5272186 Jones Dec 1993 A
5285002 Grootaert Feb 1994 A
5312935 Mayer et al. May 1994 A
5442097 Obermeier et al. Aug 1995 A
5447982 Kamba et al. Sep 1995 A
5453477 Oxenrider et al. Sep 1995 A
5463021 Beyer et al. Oct 1995 A
5478651 Tannenbaum Dec 1995 A
5488142 Fall et al. Jan 1996 A
5498680 Abusleme et al. Mar 1996 A
5530078 Felix et al. Jun 1996 A
5532310 Grenfell et al. Jul 1996 A
5562991 Tannenbaum Oct 1996 A
5576381 Bladel et al. Nov 1996 A
5591877 Obermeier et al. Jan 1997 A
5608022 Nakayama et al. Mar 1997 A
5656201 Visca et al. Aug 1997 A
5663255 Anolick et al. Sep 1997 A
5667846 Thomas Sep 1997 A
5688884 Baker et al. Nov 1997 A
5698635 Kruger et al. Dec 1997 A
5700859 Ogura et al. Dec 1997 A
5710345 Navarrini et al. Jan 1998 A
5721053 Thomas Feb 1998 A
5763552 Feiring et al. Jun 1998 A
5789083 Thomas Aug 1998 A
5789508 Baker et al. Aug 1998 A
5804650 Tsuda et al. Sep 1998 A
5874469 Maniar Feb 1999 A
5895799 Wu et al. Apr 1999 A
5955556 McCarthy et al. Sep 1999 A
5959026 Abusleme et al. Sep 1999 A
5969063 Parker et al. Oct 1999 A
5990330 Sulzbach et al. Nov 1999 A
6013795 Manzara et al. Jan 2000 A
6025307 Chittofrati et al. Feb 2000 A
6025441 Koshirai et al. Feb 2000 A
6037399 Wu et al. Mar 2000 A
6103843 Abusleme et al. Aug 2000 A
6103844 Brothers Aug 2000 A
6126849 Yamana et al. Oct 2000 A
6136893 Yamashita et al. Oct 2000 A
6153688 Miura et al. Nov 2000 A
6218464 Parker et al. Apr 2001 B1
6245923 Sulzbach et al. Jun 2001 B1
6255384 McCarthy et al. Jul 2001 B1
6255536 Worm et al. Jul 2001 B1
6267865 Polson et al. Jul 2001 B1
6365684 McCarthy et al. Apr 2002 B1
6376710 Matsumoto et al. Apr 2002 B2
6391182 Smeltzer et al. May 2002 B2
6395848 Morgan et al. May 2002 B1
6410626 Wada et al. Jun 2002 B1
6429258 Morgan et al. Aug 2002 B1
6436244 Führer et al. Aug 2002 B1
6482979 Hintzer et al. Nov 2002 B1
6503988 Kitahara et al. Jan 2003 B1
6512063 Tang Jan 2003 B2
6512089 Hintzer et al. Jan 2003 B1
6518442 Felix et al. Feb 2003 B1
6576703 Kapeliouchko et al. Jun 2003 B2
6593416 Grootaert et al. Jul 2003 B2
6602968 Bekiarian et al. Aug 2003 B1
6610788 Takakura et al. Aug 2003 B1
6613941 Felix et al. Sep 2003 B1
6624268 Maekawa et al. Sep 2003 B1
6632508 Pellerite et al. Oct 2003 B1
6642307 Sogabe et al. Nov 2003 B1
6642415 Fuhrer et al. Nov 2003 B1
6660798 Marchese et al. Dec 2003 B1
6677414 Hintzer et al. Jan 2004 B2
6686427 Katsurao et al. Feb 2004 B2
6689854 Fan et al. Feb 2004 B2
6693152 Kaspar et al. Feb 2004 B2
6703520 Hintzer et al. Mar 2004 B2
6706193 Burkard et al. Mar 2004 B1
6710123 Amin-Sanayei et al. Mar 2004 B1
6715877 Molebny Apr 2004 B2
6716942 Saito et al. Apr 2004 B1
6720437 Jones et al. Apr 2004 B2
6729437 Apple May 2004 B1
6730760 Grootaert et al. May 2004 B2
6737489 Linert et al. May 2004 B2
6750304 Kaspar et al. Jun 2004 B2
6761964 Tannenbaum Jul 2004 B2
6774164 Lyons et al. Aug 2004 B2
6794550 Hintzer et al. Sep 2004 B2
6815040 Pellerite et al. Nov 2004 B2
6822059 Buckanin et al. Nov 2004 B2
6825250 Epsch et al. Nov 2004 B2
6833403 Blädel et al. Dec 2004 B1
6846570 Leech et al. Jan 2005 B2
6861466 Dadalas et al. Mar 2005 B2
6861490 Kaspar et al. Mar 2005 B2
6869997 Wille et al. Mar 2005 B2
6878772 Visca et al. Apr 2005 B2
6956078 Cavanaugh et al. Oct 2005 B2
6972094 Ichida et al. Dec 2005 B2
7018541 Hintzer et al. Mar 2006 B2
7019163 Uematsu et al. Mar 2006 B2
7026036 Leech et al. Apr 2006 B2
7041728 Zipplies et al. May 2006 B2
7045571 Tan et al. May 2006 B2
7045591 Chen et al. May 2006 B2
7064170 Kaspar et al. Jun 2006 B2
7074862 Kaspar et al. Jul 2006 B2
7122608 Brinati et al. Oct 2006 B1
7125941 Kaulbach et al. Oct 2006 B2
7126016 Fu et al. Oct 2006 B2
7141620 Hoshikawa et al. Nov 2006 B2
7262246 Tan et al. Aug 2007 B2
7279522 Dadalas et al. Oct 2007 B2
7294276 Malvaski et al. Nov 2007 B2
7297744 Kapeliouchko et al. Nov 2007 B2
7300989 Buckanin et al. Nov 2007 B2
7342066 Dadalas et al. Mar 2008 B2
7358296 Bladel et al. Apr 2008 B2
7462667 Dadalas Dec 2008 B2
7566762 Otsuka Jul 2009 B2
7589234 Morita Sep 2009 B2
7659333 Hintzer Feb 2010 B2
7696268 Tsuda Apr 2010 B2
7714047 Tsuda May 2010 B2
7728087 Hintzer Jun 2010 B2
7838608 Hintzer Nov 2010 B2
8119750 Hintzer et al. Feb 2012 B2
20010027240 Okanishi et al. Oct 2001 A1
20010041740 Matsumoto Nov 2001 A1
20020035178 Abusleme et al. Mar 2002 A1
20020040119 Tang Apr 2002 A1
20020062161 Dusterhoft May 2002 A1
20020091212 Abusleme et al. Jul 2002 A1
20020114421 Erbes et al. Aug 2002 A1
20020123282 McCarthy et al. Sep 2002 A1
20020139593 Charaudeau et al. Oct 2002 A1
20020193500 Hintzer et al. Dec 2002 A1
20020198345 Grootaert et al. Dec 2002 A1
20030018148 Kaspar et al. Jan 2003 A1
20030032748 Hintzer et al. Feb 2003 A1
20030125421 Bladel et al. Jul 2003 A1
20030130393 Cavanaugh et al. Jul 2003 A1
20030153674 Visca et al. Aug 2003 A1
20030181572 Tan et al. Sep 2003 A1
20030220442 Epsch et al. Nov 2003 A1
20040010156 Kondo et al. Jan 2004 A1
20040016742 Miyazaki Jan 2004 A1
20040072977 Kaulbach et al. Apr 2004 A1
20040087703 Kaspar et al. May 2004 A1
20040101561 Jafari et al. May 2004 A1
20040116742 Guerra Jun 2004 A1
20040131782 Hasei et al. Jul 2004 A1
20040143052 Epsch et al. Jul 2004 A1
20040186219 Dadalas et al. Sep 2004 A1
20040242755 Araki et al. Dec 2004 A1
20050000904 Le Bec Jan 2005 A1
20050043471 Epsch et al. Feb 2005 A1
20050070633 Epsch et al. Mar 2005 A1
20050090601 Dadalas et al. Apr 2005 A1
20050090613 Maruya et al. Apr 2005 A1
20050107506 Kapeliouchko et al. May 2005 A1
20050107518 Zipplies May 2005 A1
20050113507 Bladel et al. May 2005 A1
20050113519 Buckanin et al. May 2005 A1
20050150833 Funaki et al. Jul 2005 A1
20050154104 Malvasi et al. Jul 2005 A1
20050177000 Fuhrer et al. Aug 2005 A1
20050192397 Dadalas et al. Sep 2005 A1
20050228127 Tatemoto et al. Oct 2005 A1
20060003168 Dadalas et al. Jan 2006 A1
20060014886 Hintzer et al. Jan 2006 A1
20060041051 Nakatani et al. Feb 2006 A1
20060160947 Tan et al. Jul 2006 A1
20060270864 Sumida et al. Nov 2006 A1
20060281946 Morita et al. Dec 2006 A1
20070004848 Hintzer et al. Jan 2007 A1
20070015864 Hintzer et al. Jan 2007 A1
20070015866 Hintzer et al. Jan 2007 A1
20070015937 Hintzer et al. Jan 2007 A1
20070025902 Hintzer et al. Feb 2007 A1
20070082993 Amin-Sanayei et al. Apr 2007 A1
20070117915 Funaki et al. May 2007 A1
20070135558 Tsuda et al. Jun 2007 A1
20070149733 Otsuka et al. Jun 2007 A1
20070155891 Tsuda et al. Jul 2007 A1
20070276068 Hintzer et al. Nov 2007 A1
20070276103 Guerra et al. Nov 2007 A1
20070282055 Teter et al. Dec 2007 A1
20080015304 Hintzer et al. Jan 2008 A1
Foreign Referenced Citations (122)
Number Date Country
834885 Apr 1976 BE
1044256 Dec 1978 CA
2354138 Jun 2000 CA
2000830 Sep 1970 DE
3828063 Feb 1990 DE
19932771 Jan 2001 DE
19933696 Jan 2001 DE
10018853 Oct 2001 DE
0014431 Aug 1980 EP
0 015 592 Sep 1980 EP
0015481 Sep 1980 EP
0022257 Jan 1981 EP
0190393 Aug 1986 EP
0219065 Apr 1987 EP
0222945 May 1987 EP
0250767 Jan 1988 EP
0253529 Jan 1988 EP
0519406 Dec 1992 EP
0524585 Jan 1993 EP
0525660 Feb 1993 EP
0612770 Aug 1994 EP
0625526 Nov 1994 EP
0632009 Jan 1995 EP
0649863 Apr 1995 EP
0712882 May 1996 EP
0718364 Jun 1996 EP
0739960 Oct 1996 EP
0752432 Jan 1997 EP
0816397 Jan 1998 EP
0818506 Jan 1998 EP
0822226 Feb 1998 EP
0861856 Sep 1998 EP
0890592 Jan 1999 EP
0894541 Feb 1999 EP
0964009 Dec 1999 EP
0969027 Jan 2000 EP
1059333 Dec 2000 EP
1059342 Dec 2000 EP
1067146 Jan 2001 EP
1083441 Mar 2001 EP
1160258 Dec 2001 EP
1245596 Oct 2002 EP
1323677 Jul 2003 EP
1334996 Aug 2003 EP
1364972 Nov 2003 EP
1462461 Sep 2004 EP
1533325 May 2005 EP
1514848 Apr 2006 EP
1676868 Jul 2006 EP
814839 Jun 1937 FR
642025 Aug 1950 GB
821353 Oct 1959 GB
966814 Aug 1964 GB
1034926 Jul 1966 GB
1069364 May 1967 GB
1073392 Jun 1967 GB
1127521 Sep 1968 GB
1281822 Jul 1972 GB
1349764 Apr 1974 GB
1473447 May 1977 GB
46-11031 Mar 1971 JP
58-189210 Nov 1983 JP
11349768 Dec 1999 JP
2000-128934 May 2000 JP
2002-308914 Oct 2000 JP
2002-179870 Jun 2002 JP
2002-220403 Aug 2002 JP
2002-317003 Oct 2002 JP
2003-500495 Jan 2003 JP
2003-043625 Feb 2003 JP
2003-119204 Apr 2003 JP
2003-212919 Jul 2003 JP
2003-284921 Oct 2003 JP
2004-358397 Dec 2004 JP
2004-359870 Dec 2004 JP
2005-008775 Jan 2005 JP
2005-029527 Feb 2005 JP
2005-036002 Feb 2005 JP
2005-105045 Apr 2005 JP
3758666 Mar 2006 JP
2006-513303 Apr 2006 JP
2158274 Oct 2000 RU
WO 9414904 Jul 1994 WO
WO 9624622 Aug 1996 WO
WO 9717381 May 1997 WO
WO 9850603 Nov 1998 WO
WO 9962830 Dec 1999 WO
WO 9962858 Dec 1999 WO
WO 0022002 Apr 2000 WO
WO 0035971 Jun 2000 WO
WO 0052060 Sep 2000 WO
WO 0071590 Nov 2000 WO
WO 0146116 Jun 2001 WO
WO 0157096 Aug 2001 WO
WO 0179332 Oct 2001 WO
WO 0214223 Feb 2002 WO
WO 0220676 Mar 2002 WO
WO 0244226 Jun 2002 WO
WO 02078862 Oct 2002 WO
WO 02088203 Nov 2002 WO
WO 02088206 Nov 2002 WO
WO 02088207 Nov 2002 WO
WO 02088248 Nov 2002 WO
WO 02095121 Nov 2002 WO
WO 03020836 Mar 2003 WO
WO 03051988 Jun 2003 WO
WO 03087176 Oct 2003 WO
WO 03087179 Oct 2003 WO
WO 2004031141 Apr 2004 WO
WO 2004067588 Aug 2004 WO
WO 2005003075 Jan 2005 WO
WO 2005042593 May 2005 WO
WO 2005056614 Jun 2005 WO
WO 2005063827 Jul 2005 WO
WO 2005065800 Jul 2005 WO
WO 2005082785 Sep 2005 WO
WO 2005121290 Dec 2005 WO
WO 2006011533 Feb 2006 WO
WO 2006020721 Feb 2006 WO
WO 2006135543 Dec 2006 WO
WO 2006135825 Dec 2006 WO
WO 2007120348 Oct 2007 WO
Non-Patent Literature Citations (34)
Entry
ASTM D 4895-04, “Standard Specification for Polytetrafluoroethylene (PTFE) Resin Produced From Dispersion”, pp. 1-14, 2006.
Apostolo et al., “Microemulsion Polymerization for Producing Fluorinated Structured Materials”, Macromol. Symp. 2004, 206, pp. 347-360.
“Basic Physical Properties of Chemical Compounds”, Knovel Critical Tables 2008, 2nd edition.
Candau, “Inverse Emulsion and Microemulsion Polymerization”, Emulsion Polymerization and Emulusion Polymers, John Wiley & Sons, 1997, Chapter 21.
Chi et al., “A Facile Synthesis of Partly-fluorinated Ethers Using Perfluroporpoxyethylene and Aliphatic Alcohols”, Bull. Korean Chem. Soc., 1999, vol. 20, No. 2, pp. 220-222.
Drobny, Technology of Fluoropolymers, CRC Press LLC, 2001, p. 35.
Ebnesajjad, “Fluoroplastics, vol. 1, Non-Melt Processible Fluoroplastics”, Plastics Design Library, NY, 2000, pp. 285-295.
Ebnesajjad, “Fluoroplastics, vol. 2, Melt Processible Fluoropolymers”, Plastics Design Library, NY, 2003, pp. 1-21.
Encyclopedia of Polymer Science and Engineering, John Wiley & Sons, vol. 7, 1987, pp. 211-233.
England, “Catalytic Conversion of Fluoroalkyl Alkyl Ethers to Carbonyl Compounds”, J. Org. Chem., 1984, vol. 49, pp. 4007-4008.
Furin et al., “Interaction of 1, 1, 2-Trifluoro-2-Hexafluoro-2′ (Heptafluoropropoxy)-Propoxyethylene with Alcohols in the presence of bases”, Journal of Applied Chemistry, vol. 72, Issue 1, 1999, pp. 125-133.
Furin et al., “Reaction of 1, 1,2-trifluoro-2-hexafluoro-2′-(heptafluoropropoxy)-propoxyethylene with amines or alcohols,” Journal of Fluorine Chemistry, vol. 106, Mar. 2000, pp. 13-24.
Griffin, “Calculation of HLB Valves of Non-Ionic Surfactants”, Journal of the Society of Cosmetic Chemists, 1954, vol. 5, pp. 249-259.
“Guide to Protein Purification, Methods in Enzymology,” Deutscher, M. vol. 182, 24. 1990. (pp. 309-317).
Harrison, D. et al., “Polycyclic Fluoroaromatic Compounds—III: Octafluoroacenaphthylene, and Decafluoro-Indane, -Acenaphthene, -Anthracene, and -Pyrene,” Tetrahedron, vol. 19, 1963, pp. 1893-1901.
Hu et al., “High Nucleophilicity of Formate Toward Polyhalofluorocalkenes,” Chinese Chem. Letters, vol. 3, No. 2, 1992, pp. 87-92.
“Hydrogen-Ion Activity to Laminated Materials, Glass,” Encyclopedia of Chemical Technology. John Wiley & Sons, vol. 13, 3rd Ed. 1981. (p. 687).
“Immobilized Biocatalysts to Isoprene,” Ullmann's Encyclopedia of Industrial Chemistry. vol. A14. 1985. (p. 439-459).
“Identification to Lignin,” Encyclopedia of Polymer Science and Engineering. John Wiley & Sons, vol. 8. 1987 (p. 347).
Ivanova et al., “Synthesis of Alcohols from Perfluorvinyl Esters”, Zh. Vses. Khim Obsh 1999, (24), pp. 656-657.
Kokelenberg, “A New Type of Fluortensides, based on the Addition of Nuclephiles to Chlorotrifluorothylene and Hexafluoropropylene,” Tenside Detergents, vol. 22, No. 1, 1985, pp. 22-27.
Lampert, D.J. et al., “Removal of Perfluorooctanoic Acid and Perfluorooctane Sulfaonate from Wasterwater by Ion Exchange”, Practice of Periodical of Hazardous, Toxic and Radioactive Waste Management, Jan. 2007, vol. 11, No. 1, pp. 60-68.
LaZerte, “The Free-radical Catalyzed Addition of Alcohols and Aldehydes to Perfluoroolefins”, Journal Am. Chem. Soc., vol. 77, No. 4, Feb. 20, 1955, pp. 910-917.
Mark et al., Encyclopedia of Polymer Science and Engineering, John Wiley & Sons, 1989, vol. 16, p. 580.
“Nonionic Surfactants.” Edited by Martin J. Schick. 1967.
Schiers, “Modern Fluoropolymers: High Performance Polymers for Diverse Applications,” John Wiley & Sons, 1997.
Storsberg, Joachim and Ritter, Helmut, “Cyclodextrins in Polymer Synthesis: A ‘Green’ Route to Fluorinated Polymers via Cyclodextrin Complexes in Aqueous Solution”, Macromol. Chem Phys., 2002, pp. 812-818.
Sudol et al., “Miniemulsion Polymerization”, Emulsion Polymerization and Emulsion Polymers, John Wiley & Sons, 1997, Chapter. 20.
Sullivan “Synthesis of Perfluoroalkyl Vinyl Ether Acids and Derivatives,” Journal of Organic Chemistry, vol. 34, No. 6, Jun. 1969, p. 1841-1844.
Tosler et al., “Ethoxylated Alkyl Amines”, Handbook of Detergents, Published by CRC Press, 1999, pp. 26-27.
International Search Report, PCT/US2006/062300, 4 pages, Nov. 6, 2007.
Written Opinion of the International Searching Authority, PCT/US2006/062300, 5 pages, Nov. 6, 2007.
Search Report for International Application No. PCT/US2002/25114, dated Dec. 12, 2002, 3 pages.
International Search Report and Written Opinion PCT/US2008/073251, dated Feb. 24, 2009, 8 pages.
Related Publications (1)
Number Date Country
20120190807 A1 Jul 2012 US
Divisions (1)
Number Date Country
Parent 11457239 Jul 2006 US
Child 13403724 US